Investment analysts at StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Free Report) in a research note issued on Monday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Trading Down 1.6 %
NASDAQ:CPIX opened at $1.22 on Monday. The company has a market cap of $17.31 million, a PE ratio of -2.07 and a beta of 0.20. The company has a current ratio of 1.44, a quick ratio of 1.26 and a debt-to-equity ratio of 0.62. The company has a 50 day simple moving average of $1.38 and a two-hundred day simple moving average of $1.52. Cumberland Pharmaceuticals has a 12 month low of $1.22 and a 12 month high of $2.36.
Cumberland Pharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Cumberland Pharmaceuticals
- How Technical Indicators Can Help You Find Oversold Stocks
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Pros And Cons Of Monthly Dividend Stocks
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is a Secondary Public Offering? What Investors Need to Know
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.